Injection of human mutant KRAS cells infected with the inducible FOSL1 shRNA into immunodeficient mice treated with doxycycline yielded tumours of significant smaller volume than control cells (Fig. 3d and Supplementary Fig. 3g). Here, FOSL1 is linked to neoplasm.